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Schwannomas arise from the Schwann cells that cover
the peripheral nerves. Most of them are benign.
Malignant schwannomas are most commonly seen in the
proximal parts of the upper and lower extremities and
trunk (1,2). A malignant schwannoma of the small
intestine is an extremely rare disease. Only 24 cases have
been reported in the English language medical literature
(3).
We report a case of a malignant schwannoma of the
small intestine in a 53-year-old woman.

Case Report
A 53-year-old woman was admitted to the hospital in
June 1999 because of abdominal pain. On clinical
examination, an abdominal mass was found. Ultrasound
scanning confirmed the mass. A contrast enhanced CT
scan of the abdomen revealed a round semisolid
heterogeneous well-defined mass (Figure 1). The
presumed diagnosis was intestinal carcinoma. No evidence of metastasis was found. The patient did not have
neurofibromatosis.
At surgery, the tumor was found in the distal portion
of the ileum. Total excision of the tumor with 100 cm
resection of the distal ileum was performed. Exploration
of the abdomen revealed no carcinomatosis. The liver was
unremarkable, and no peritoneal lesions were identified.
Macroscopic pathological examination showed a 100
cm resected ileum, and a tan-gray solid tumor measuring
14x13x8 cm encircling the distal ileum. The tumor mass
was adherent to the serosal surface of the ileum and

Figure 1.

A contrast enhanced CT scan of the abdomen demonstrated
a round semisolid heterogeneous well-defined mass.

penetrated the other layers of the distal ileum. The cut
surface of the tumor had a gray-white appearance, small
cysts, and areas of hemorrhage and necrosis. The surgical
margins were negative for the tumor.
Histologically, the tumor showed malignant spindle
cells and grew invasively through the intestinal wall. In
some areas the tumor had a loose background (Figure
2). The tumor cells had nuclear irregularity, and mitotic
activity was easily found. Nucleoli were seen in many
tumor cells. In some areas, the tumor contained cartilage
and glands made up of well-differentiated, non-ciliated
cuboidal cells with clear cytoplasm (Figure 3).
Histochemically, the van Gieson stain was negative.
Several immunohistochemical stains were used.
For immunohistochemical staining, tissues were fixed
in 10% formaldehyde overnight and embedded in
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Figure 2.

The tumor showing malignant spindle cell within loose
background (HE, x200).

Figure 3.

The tumor having a gland made up of non-ciliated cuboidal
cells and cartilage (HE, x100).

paraffin. Sections were cut 4 µm thick, dewaxed in
xylene, and incubated for 20 minutes in 0.3% H2O2 to
block endogenous peroxidase activity. The sections were
then microwaved for four minutes in PBS (phosphate
buffer saline), and incubated with the primary antibody
overnight at room temperature. The primary antibody
was visualized with diaminobenzidine as chromogen. The
sections were counterstained in hematoxylin and eosin,
cleared with xylene and coverslipped.

of recurrence. The patient was well 11 months after
surgery.

S-100 protein and vimentin were diffusely positive,
whereas neuron specific enolase was focally positive
(Figure 4). In immunohistochemical staining, keratin,
smooth muscle actin and desmin were negative. The
pathological diagnosis was malignant schwannoma.
The patient was followed up regularly for eleven
month at our hospital. We have not detected any evidence

The clinical symptoms of an intestinal malignant
schwannoma include fatigue, weight loss and abdominal
discomfort. Intestinal obstruction due to compression
may cause pain and later ileus may develop. Because these
symptoms are usually non-specific and vague, the
diagnosis is often late. The preoperative diagnosis of
malignant schwannoma of the small intestine may be

Figure 4-A. Neuron specific enolase focal immunoreactivity in spindle
tumor cells (labelled streptavidin biotin method, x200).

Figure 4-B. S-100 weakly focal immunoreactivity in spindle tumor cells
(labelled streptavidin biotin method, x200).
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Malignant schwannomas most commonly arise from
the proximal parts of the upper and lower extremities and
trunk. A few cases have been reported within the head
and neck regions, whereas malignant schwannoma of the
small intestine is extremely rare (1,2). The tumor is
typically a disease of adult life. Most of them occur in
patients between 20 and 50 years of age (3,4).
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difficult. A palpable mass may be found in the abdomen,
as in our patient (3).
There seems to be no characteristic macroscopic
picture of malignant schwannoma. The gross appearance
is similar to that of other soft tissue sarcomas. The tumor
is large and areas of hemorrhage and necrosis are seen.
Most malignant schwannomas are quite easily diagnosed
as malignancies (5).
It is important to distinguish them from other
sarcomas. One of the best ways to differentiate
leiomyosarcomas from malignant schwannomas is by
light microscopy with van Gieson staining. Also, the
immunoreaction for actin is positive in leiomyosarcomas
(3,5).
Malignant schwannomas are diagnosed based on the
mitotic activity of the tumor. Areas of hemorrhage and
necrosis also suggest malignancy. Both benign and
malignant Schwann cell neoplasms may contain areas of
nuclear atypia, epithelioid areas, melanocytic
differentiation, and other mesenchymal elements. Areas
of chondrosarcoma, osteosarcoma and angiosarcoma can
also be seen (1). Classical schwannomas and malignant
schwannomas are immunoreactive for S100, leu7,
laminin and glial fibrillary acidic protein, whereas the
immunoreaction for desmin is negative in malignant
schwannomas (3,1).
On rare occasions, the glands in these tumors may be
difficult to distinguish from biphasic synovial sarcomas
because the glandular elements may be virtually identical

(1). Malignant schwannomas arise from the peripheral
nerve sheath, whereas synovial sarcomas have an
anatomic relationship to a joint. In our patient, the
tumor’s location and the gross and microscopic features
of the tumor helped us to distinguish between synovial
sarcomas and malignant schwannomas. Also, the negative
immunostaining for keratin favors malignant
schwannoma (6).
Although the glandular elements set this tumor apart
as a peculiar histological variant, they essentially serve no
role in predicting its biological behavior. The source of the
epithelial elements of the glands within these tumors has
remained controversial. Some authors have suggested
that they arise from heterotopic ependymal cells located
within the peripheral nerve, and some authors claim to
have documented ependymal features (1).
The primary treatment is surgical. Remission after
chemotherapy has been reported. Among the 24
reported patients with a malignant schwannoma of the
small intestine, only two patients survived for more than
five years. Because of the great risk of recurrence,
patients with a malignant schwannoma must be followed
up by abdominal CT or ultrasonography after surgery (3).
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